D. K. Armstrong
Oncology · 2011
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 9 citations into it
Whom D. K. Armstrong trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Alan Ashworth (in Oncology)
Papers from D. K. Armstrong's perspective
Ordered by how strongly the researchers D. K. Armstrong trusts endorse each paper. Same corpus, a different order for every researcher.
- Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. (Journal of the National Cancer Institute)
- Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. (Journal of Clinical Oncology)
- A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. (Journal of Clinical Oncology)
- Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. (New England Journal of Medicine)
- Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. (Journal of Clinical Oncology)
- Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. (Journal of Clinical Oncology)
- Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2
- Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer. (Journal of Clinical Oncology)
- Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. (Journal of Clinical Oncology)
- Grading Ovarian Serous Carcinoma Using a Two-Tier System (American Journal of Surgical Pathology)
Their papers
- Recent Progress in the Diagnosis and Treatment of Ovarian Cancer (2011) — 798 citations